Skip to main content
Clinical Trials/ISRCTN18414398
ISRCTN18414398
Completed
未知

Autoimmunity-informed Phenotyping In patients with Fibromyalgia syndrome (APIF)

niversity of Liverpool0 sites113 target enrollmentMarch 15, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
niversity of Liverpool
Enrollment
113
Status
Completed
Last Updated
last year

Overview

Brief Summary

2022 Results article in https://doi.org/10.1093/pm/pnac089 (added 12/02/2024)

Registry
who.int
Start Date
March 15, 2019
End Date
August 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Liverpool

Eligibility Criteria

Inclusion Criteria

  • 1\. Fibromyalgia syndrome of more than 1 year duration, without other conditions that could explain participant's widespread pain in the view of the investigator
  • 2\. ACR Fibromyalgia Criteria 2010 or 1990
  • 3\. Aged 18 years and above
  • 4\. Average weekly pain intensity of 4/10 or higher on a 11\-point numeric rating scale (0\-10 NRS)

Exclusion Criteria

  • 1\. Pregnant or breastfeeding
  • 2\. Unable to read or understand the standard questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials